Angel Gil Hernández (born 1951, Granada) is a Spanish professor at the
University of Granada (UGR), Spain in the Department of Biochemistry and Molecular Biology. He is also the Honorary President of the Ibero-American Nutrition Foundation (FINUT).[1]
Early life and education
Gil was born in
Granada, Spain in 1951. He earned his degree in Biology at the University of Granada, followed by his PhD in
Biological Sciences from the same university.
Research and career
The study of the function of dietary
nucleotides in early life and the creation of baby nutrition products are just two of professor Gil's many research interests.[2][3] Additionally, the design, development, and assessment of enteral clinical nutrition products, as well as the isolation, identification, and description of the mechanism of action of probiotics and the metabolic, molecular, and genetic factors involved in obesity and the early onset of the metabolic syndrome (MS) in childhood. Having about 50 years of professional experience, Gil is currently an
Emeritus Professor at the University of Granada.
Awards and honors
Gil has been honoured with many awards including the Class Fellow of the American Society of Nutrition (2022).
Patents
Gil has filed many patents for his inventions.
"Fat mixture for child and adult nutrition," (1994).[4]
"Nourishing products enriched with nucleosides and/or nucleotides for infants and adults and processes for their preparation," (1996).[5]
"Protein mixture and use thereof in the preparation of a product that is intended for oral or enteral food," (2008).[6]
"Food product for enteral or oral nutrition," (2008).[7]
"
Lipid mixture and use thereof in the preparation of a product that is intended for enteral or oral administration," (2009, application since abandoned).[8]
"Food product for enteral or oral nutrition," (2009, application since abandoned).[9]
"Mixture of carboyhydrates and its use in the preparation of a product intended for oral or
enteral nutrition," (2011, application since abandoned).[10]
"
Functional food supplement intended, in particular, for nutrition and for prevention and improvement in cases of neurological alterations
neurodegenerative alterations or
cognitive disorders," (2013, application withdrawn).[11]
"Enteral or oral food product intended, in particular, for nutrition and for the prevention and improvement of neurological alterations, neurodegenerative alterations or cognitive disorders," (2013, application withdrawn).[12]
"Isolation, identification and characterization of strains with
probiotic activity, from
faeces of infants fed exclusively with breast milk," (2014).[13]
Publications
A Stephen, M Alles, C De Graaf, M Fleith, E Hadjilucas, E Isaacs, C Maffeis, G Zeinstra, Christophe Matthys, A Gil. "The role and requirements of digestible dietary carbohydrates in infants and toddlers".[14]
Ricardo Uauy, Richard Quan, Angel Gil. "Role of nucleotides in intestinal development and repair: implications for infant nutrition".[15]
N Nieto, MI Torres, MI Fernandez, MD Giron, A Rios, MD Suarez, A Gil. "Experimental ulcerative colitis impairs antioxidant defence system in rat intestine".[16]
Angel Gil, Rosa M Ortega, José Maldonado. "Wholegrain cereals and bread: a duet of the Mediterranean diet for the prevention of chronic diseases". Public health nutrition.[17]
Angel Gil, Fernando Gil. "Fish, a Mediterranean source of n-3 PUFA: benefits do not justify limiting consumption".[18]
^ES 2033193, Gil Hernandez, Angel; Moreno Carretero, Jose & Jimenez Lopez, Jesus, "Fat mixture for infant and adult nutrition", published 1994-01-16, assigned to Unión Industrial y Agro-Ganadera SA
^CA 1338427, Gil Hernandez, Angel; Morales Villena, Daniel & Valverde Rodriguez-Bolivar, Eduardo, "Nourishing products enriched with nucleosides and/or nucleotides for infants and adults and processes for their preparation", published 1996-07-02, assigned to
Abbott Laboratories
^EP 1972346, Gil Hernández, Angel; Martínez de Victoria Muñoz, Emilio & San Román Pais, Paloma, "Protein mixture and use thereof in the preparation of a product that is intended for oral or enteral food", published 2008-09-24, assigned to Vegenat SA
^EP 1972345, Gil Hernández, Angel; Martínez de Victoria Muñoz, Emilio & San Román Pais, Paloma et al., "Food product for enteral or oral nutrition", published 2008-09-24, assigned to Vegenat SA
^US application 2009252853, Gil Hernandez, Angel; Martinez De Victoria Munoz, Emilio & San Roman Pais, Paloma et al., "Lipid mixture and use thereof in the preparation of a product that is intended for enteral or oral administration", published 2009-10-08, subsequently abandoned.
^US application 2009137459, Gil Hernández, Angel; Martínez de Victoria Muñoz, Emilio & San Román Pais, Paloma et al., "Food product for enteral or oral nutrition", published 2009-05-28, assigned to Vegenat SA, since abandoned.
^US application 2011053888, Gil Hernandez, Angel; San Roman Pais, Paloma & Perez, Rodriguez Milagros, "Mixture of carboyhydrates and its use in the preparation of a product intended for oral or enteral nutrition", published 2011-03-03, assigned to Vegenat SA, since abandoned.
^EP application 2554058, Gil Hernandez, Angel; San Roman Pais, Paloma & Perez, Rodriguez Milagros, "Functional food supplement intended, in particular, for nutrition and for prevention and improvement in cases of neurological alterations, neurodegenerative alterations or cognitive disorders", published 2013-12-25, assigned to Vegenat SA, since withdrawn.
^EP application 2554057, Gil Hernandez, Angel; San Roman Pais, Paloma & Perez, Rodriguez Milagros, "Enteral or oral food product intended, in particular, for nutrition and for the prevention and improvement of neurological alterations, neurodegenerative alterations or cognitive disorders", published 2013-02-06, assigned to Vegenat SA, since withdrawn.
^US 8637297, Vieites Fernandez, Jose Maria; Munoz Quezada, Sergio & Llamas Company, Inmaculada et al., "Isolation, identification and characterization of strains with probiotic activity, from faeces of infants fed exclusively with breast milk", published 2014-01-28, assigned to
Hero AG